Company Overview

Update
Founded:
1997
Headquarters:
Tucson, AZ
Funding:
$31.2M
Categories:
Biotechnology
Description:
HTG Molecular Diagnostics develops assays and reagent systems for gene expression analysis.

Detailed Description

Update

HTG Molecular Diagnostics is a leading provider of molecular-based technology solutions for gene expression profiling, miRNA, siRNA and mRNA measurement for translational medicine and diagnostic applications. The Company's qNPA molecular technology platform is well-suited for reliably detecting small, yet important, changes in gene expression levels in a variety of sample types. Privately-held HTG is based Tucson, Arizona.

Current Team (11)

Update

Past Team (1)

Update
  • Cb default image

    Steve Hagan

    Executive Vice President, Commercial Operations

Funding Rounds (4) - $31.2M

Update

Board Members and Advisors (9)

Update

Investors (5)

Update
  • 29c01db5dd11b178b4bb308cec4bf8bd

    SR One

    Venture Capital
  • 0c6b7d3c490ac6ea1f104fc09cda3f3f

    Novo A/S

    Novo A/S is the holding company of the Novo Group, wholly-owned by the Novo Nordisk Foundation.
  • Rqlu83dt5p7d56ekxdlx

    Fletcher Spaght Ventures

    Venture Capital Firm
  • 749eece6c26a521e2f44b9c4bf62100e

    Merck Capital Ventures

    Merck Capital Ventures invests in companies in various stages of development from the first round...
  • 056392a553702a037f3e1aae67f23933

    Solstice Capital

    Solstice Capital seeks superior venture capital returns for its limited partners through...

Offices/Locations (1)

Update
  • Office

    3430 E. Global Loop

    Tucson, AZ 85706

    USA

Images (1)

Update
  • Sruuxjwu7lbdl91nfut2